Brief: Arrowhead Pharmaceuticals Files Complaint For Declaratory Judgment Against Ionis Pharmaceuticals
11/09/2025 12:43
Sept 11 (Reuters) - Arrowhead Pharmaceuticals Inc ARWR.O: ARROWHEAD PHARMACEUTICALS: FILES COMPLAINT FOR DECLARATORY JUDGMENT AGAINST IONIS PHARMACEUTICALS ARROWHEAD PHARMACEUTICALS: NOT SEEKING MONETARY RELIEF IN COMPLAINT AGAINST IONIS PHARMACEUTICALS Source text: ID:nBw15MFmga Further company coverage: ARWR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors